SCHEMBL537223

SCHEMBL537223

COC(=O)c1ccc([N+](=O)[O-])c(C=O)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 3/20 0.62
VCAM1 P19320 1/20 0.56
ALDH1A1 P00352 4/20 0.50
MAPT P10636 2/20 0.50
KDM4E B2RXH2 1/20 0.50
CYP3A4 P08684 1/20 0.50
ALOX15 P16050 1/20 0.50
PRKDC P78527 1/20 0.50
HSD17B10 Q99714 1/20 0.50
AR P10275 1/20 0.48
PELP1 Q8IZL8 1/20 0.48
HPGD P15428 2/20 0.48
NPSR1 Q6W5P4 2/20 0.48
PKM P14618 1/20 0.47
AKR1C4 P17516 1/20 0.47
AKR1C3 P42330 1/20 0.47
AKR1C2 P52895 1/20 0.47
AKR1C1 Q04828 1/20 0.47
LMNA P02545 1/20 0.46
POLB P06746 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL192836 0.88 ERN1 (0.62) ERN1VCAM1ALDH1A1MAPTKDM4E
SCHEMBL10061493 0.84 ERN1 (0.46) ERN1VCAM1ALDH1A1MAPTKDM4E
SCHEMBL537387 0.84 VCAM1 (0.52) ERN1VCAM1ALDH1A1MAPTAR
SCHEMBL28809247 0.84 KMT2A (0.57) ERN1ALDH1A1MAPTKDM4EPKM
Dimethylamine SCHEMBL7140666 0.84 VCAM1 (0.52) ERN1VCAM1ALDH1A1MAPTAR
SCHEMBL7085039 0.83 VCAM1 (0.51) ERN1VCAM1ALDH1A1MAPTAR
SCHEMBL7085042 0.83 VCAM1 (0.51) ERN1VCAM1ALDH1A1MAPTAR
SCHEMBL18775437 0.83 MAPK1 (0.49) ERN1ALDH1A1MAPTKDM4ECYP3A4
SCHEMBL5734347 0.82 VCAM1 (0.68) ERN1VCAM1ALDH1A1MAPTKDM4E
SCHEMBL3970653 0.82 VCAM1 (0.50) ERN1VCAM1ALDH1A1MAPTAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 183 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114751765-B Porous biological filter material for biological aerated filter and preparation method thereof 安徽能泰高科环保技术有限公司 2022-12-09 CN claimed
CN-114751765-A Porous biological filter material for biological aerated filter and preparation method thereof 安徽能泰高科环保技术有限公司 2022-07-15 CN claimed
EP-1817283-A1 2-SUBSTITUTED INDOLES, THEIR PRECURSORS AND NOVEL PROCESSES FOR THE PREPARATION THEREOF Lautens, Mark (CA) 2007-08-15 EP claimed
WO-2006047888-A1 2-SUBSTITUTED INDOLES, THEIR PRECURSORS AND NOVEL PROCESSES FOR THE PREPARATION THEREOF LAUTENS MARK (CA) 2006-05-11 WO claimed
EP-4605392-A1 METHODS FOR TREATING CANCER Antares Therapeutics, Inc. (US) 2025-08-27 EP disclosed
US-12291504-B2 Small molecule inhibition of sulfotransferase SULT1A3 University of Pittsburgh—of the Commonwealth System of Higher Education (US) 2025-05-06 US disclosed
WO-2025082069-A1 COMPOUND BINDING TO CRBN PROTEIN AND DEGRADATION AGENT OF PROTEIN 中国海洋大学 2025-04-24 WO disclosed
CN-115427035-B ENL/AF9 YEATS inhibitors 洛克菲勒大学 2025-04-22 CN disclosed
CN-119841843-A Compound combined with CRBN protein and degradation agent of CRBN protein 中国海洋大学 2025-04-18 CN disclosed
CN-112679467-B Heterocyclic substituted bicyclic ring Azole pesticides FMC公司 2024-11-01 CN disclosed
WO-2024178390-A1 COVALENT MODIFIERS OF AKT1 AND USES THEREOF TERREMOTO BIOSCIENCES, INC. (US) 2024-08-29 WO disclosed
CN-118359604-A Protein arginine methyltransferase inhibitors 华润医药研究院(深圳)有限公司 2024-07-19 CN disclosed
US-5874466-A REACTING AMINE AND ACYL CHLORIDE, HYDROGENOLYSIS ROHM AND HAAS COMPANY (US) 1999-02-23 US disclosed
EP-0880893-A1 Method for controlling algae ROHM AND HAAS COMPANY (US) 1998-12-02 EP disclosed
EP-0878192-A2 Method for treating protozoal infections Allegheny University of The Health Sciences (US) 1998-11-18 EP disclosed
CN-1198330-A Method for treating protozoal infections ALLEGHENY UNIVERSITY OF THE HE (US) 1998-11-11 CN disclosed
EP-0843018-A1 Use of certain amides as probes for detection of antitubulin activity and resistance monitoring ROHM AND HAAS COMPANY (US) 1998-05-20 EP disclosed
EP-0834311-A1 Method for inhibiting the growth of mammalian cells ROHM AND HAAS COMPANY (US) 1998-04-08 EP disclosed
EP-0816328-A2 Process for the manufacture of acetonylbenzamides ROHM AND HAAS COMPANY (US) 1998-01-07 EP disclosed
EP-0816331-A1 Fungicidally active n-acetonylbenzamide compounds ROHM AND HAAS COMPANY (US) 1998-01-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12291504-B2 Small molecule inhibition of sulfotransferase SULT1A3 SULT1A1, SULT2A1, SULT1E1 ERN1 2259/4885VCAM1 2242/4885ALDH1A1 176/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.